Calliditas Therapeutics AB (publ) CALT
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |
| Mark N. Lampert | United States | 0 | 0 | 0 | 0 | 0 | 0 % | 11/09/2024 |